β-ニコチンアミドモノヌクレオチド（NMN）のグローバル市場 2021年：企業別、地域別、種類・用途別

• 英文タイトル：Global β-Nicotinamide Mononucleotide (NMN) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-203B04777 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、86ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

β-ニコチンアミドモノヌクレオチド（NMN）市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のβ-ニコチンアミドモノヌクレオチド（NMN）の市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界のβ-ニコチンアミドモノヌクレオチド（NMN）の市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 β-ニコチンアミドモノヌクレオチド（NMN）市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・98％以上、98％以下 用途別セグメントは次のように区分されます。 ・医療製品、化粧品、その他 世界のβ-ニコチンアミドモノヌクレオチド（NMN）市場の主要な市場プレーヤーは以下のとおりです。 ・GeneHarbor、Herbalmax、Genex Formulas、Shinkowa Pharmaceutical、Maac10 Formulas、EffePharm、Bontac、CELFULL、Kingdomway 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、β-ニコチンアミドモノヌクレオチド（NMN）製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なβ-ニコチンアミドモノヌクレオチド（NMN）メーカーの企業概要、2019年～2021年までのβ-ニコチンアミドモノヌクレオチド（NMN）の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なβ-ニコチンアミドモノヌクレオチド（NMN）メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別β-ニコチンアミドモノヌクレオチド（NMN）の販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までのβ-ニコチンアミドモノヌクレオチド（NMN）の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域でのβ-ニコチンアミドモノヌクレオチド（NMN）市場予測を収録しています。 ・第12、13、14章では、β-ニコチンアミドモノヌクレオチド（NMN）の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：GeneHarbor、Herbalmax、Genex Formulas、Shinkowa Pharmaceutical、Maac10 Formulas、EffePharm、Bontac、CELFULL、Kingdomway ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：98％以上、98％以下 ・用途別分析2016年-2026年：医療製品、化粧品、その他 ・β-ニコチンアミドモノヌクレオチド（NMN）の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・β-ニコチンアミドモノヌクレオチド（NMN）のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・β-ニコチンアミドモノヌクレオチド（NMN）のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・β-ニコチンアミドモノヌクレオチド（NMN）の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・β-ニコチンアミドモノヌクレオチド（NMN）の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The β-Nicotinamide Mononucleotide (NMN) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global β-Nicotinamide Mononucleotide (NMN) size is estimated to be million in 2021 from USD 214.6 million in 2020, with a change of % between 2020 and 2021. The global β-Nicotinamide Mononucleotide (NMN) market size is expected to grow at a CAGR of 8.1% for the next five years.

Market segmentation
β-Nicotinamide Mononucleotide (NMN) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Above 98%
Below 98%

Market segment by Application can be divided into
Health Care Products
Cosmetics
Others

The key market players for global β-Nicotinamide Mononucleotide (NMN) market are listed below:
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe β-Nicotinamide Mononucleotide (NMN) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of β-Nicotinamide Mononucleotide (NMN), with price, sales, revenue and global market share of β-Nicotinamide Mononucleotide (NMN) from 2019 to 2021.
Chapter 3, the β-Nicotinamide Mononucleotide (NMN) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the β-Nicotinamide Mononucleotide (NMN) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and β-Nicotinamide Mononucleotide (NMN) market forecast, by regions, content and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe β-Nicotinamide Mononucleotide (NMN) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 β-Nicotinamide Mononucleotide (NMN) Introduction
1.2 Market Analysis by Content
1.2.1 Overview: Global β-Nicotinamide Mononucleotide (NMN) Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Above 98%
1.2.3 Below 98%
1.3 Market Analysis by Application
1.3.1 Overview: Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Health Care Products
1.3.3 Cosmetics
1.3.4 Others
1.4 Global β-Nicotinamide Mononucleotide (NMN) Market Size & Forecast
1.4.1 Global β-Nicotinamide Mononucleotide (NMN) Sales in Value (2016-2026))
1.4.2 Global β-Nicotinamide Mononucleotide (NMN) Sales in Volume (2016-2026)
1.4.3 Global β-Nicotinamide Mononucleotide (NMN) Price by Type (2016-2026) & (US$/Kg)
1.5 Global β-Nicotinamide Mononucleotide (NMN) Production Capacity Analysis
1.5.1 Global β-Nicotinamide Mononucleotide (NMN) Total Production Capacity (2016-2026)
1.5.2 Global β-Nicotinamide Mononucleotide (NMN) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 β-Nicotinamide Mononucleotide (NMN) Market Drivers
1.6.2 β-Nicotinamide Mononucleotide (NMN) Market Restraints
1.6.3 β-Nicotinamide Mononucleotide (NMN) Trends Analysis
2 Manufacturers Profiles
2.1 GeneHarbor
2.1.1 GeneHarbor Details
2.1.2 GeneHarbor Major Business
2.1.3 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Product and Services
2.1.4 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Herbalmax
2.2.1 Herbalmax Details
2.2.2 Herbalmax Major Business
2.2.3 Herbalmax β-Nicotinamide Mononucleotide (NMN) Product and Services
2.2.4 Herbalmax β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Genex Formulas
2.3.1 Genex Formulas Details
2.3.2 Genex Formulas Major Business
2.3.3 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Product and Services
2.3.4 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Shinkowa Pharmaceutical
2.4.1 Shinkowa Pharmaceutical Details
2.4.2 Shinkowa Pharmaceutical Major Business
2.4.3 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Product and Services
2.4.4 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Maac10 Formulas
2.5.1 Maac10 Formulas Details
2.5.2 Maac10 Formulas Major Business
2.5.3 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Product and Services
2.5.4 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 EffePharm
2.6.1 EffePharm Details
2.6.2 EffePharm Major Business
2.6.3 EffePharm β-Nicotinamide Mononucleotide (NMN) Product and Services
2.6.4 EffePharm β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Bontac
2.7.1 Bontac Details
2.7.2 Bontac Major Business
2.7.3 Bontac β-Nicotinamide Mononucleotide (NMN) Product and Services
2.7.4 Bontac β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 CELFULL
2.8.1 CELFULL Details
2.8.2 CELFULL Major Business
2.8.3 CELFULL β-Nicotinamide Mononucleotide (NMN) Product and Services
2.8.4 CELFULL β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Kingdomway
2.9.1 Kingdomway Details
2.9.2 Kingdomway Major Business
2.9.3 Kingdomway β-Nicotinamide Mononucleotide (NMN) Product and Services
2.9.4 Kingdomway β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 β-Nicotinamide Mononucleotide (NMN) Sales by Manufacturer
3.1 Global β-Nicotinamide Mononucleotide (NMN) Sales in Volume by Manufacturer (2019-2021e)
3.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in β-Nicotinamide Mononucleotide (NMN)
3.4 Market Concentration Rate
3.4.1 Top 3 β-Nicotinamide Mononucleotide (NMN) Manufacturer Market Share
3.4.2 Top 6 β-Nicotinamide Mononucleotide (NMN) Manufacturer Market Share
3.5 Global β-Nicotinamide Mononucleotide (NMN) Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and β-Nicotinamide Mononucleotide (NMN) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global β-Nicotinamide Mononucleotide (NMN) Market Size by Region
4.1.1 Global β-Nicotinamide Mononucleotide (NMN) Sales in Volume by Region (2016-2026)
4.1.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2016-2026)
4.2 North America β-Nicotinamide Mononucleotide (NMN) Revenue (2016-2026)
4.3 Europe β-Nicotinamide Mononucleotide (NMN) Revenue (2016-2026)
4.4 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Revenue (2016-2026)
4.5 South America β-Nicotinamide Mononucleotide (NMN) Revenue (2016-2026)
4.6 Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Revenue (2016-2026)
5 Market Segment by Type
5.1 Global β-Nicotinamide Mononucleotide (NMN) Sales in Volume by Type (2016-2026)
5.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Type (2016-2026)
5.3 Global β-Nicotinamide Mononucleotide (NMN) Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global β-Nicotinamide Mononucleotide (NMN) Sales in Volume by Application (2016-2026)
6.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2016-2026)
6.3 Global β-Nicotinamide Mononucleotide (NMN) Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America β-Nicotinamide Mononucleotide (NMN) Sales by Type (2016-2026)
7.2 North America β-Nicotinamide Mononucleotide (NMN) Sales by Application (2016-2026)
7.3 North America β-Nicotinamide Mononucleotide (NMN) Market Size by Country
7.3.1 North America β-Nicotinamide Mononucleotide (NMN) Sales in Volume by Country (2016-2026)
7.3.2 North America β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe β-Nicotinamide Mononucleotide (NMN) Sales by Type (2016-2026)
8.2 Europe β-Nicotinamide Mononucleotide (NMN) Sales by Application (2016-2026)
8.3 Europe β-Nicotinamide Mononucleotide (NMN) Market Size by Country
8.3.1 Europe β-Nicotinamide Mononucleotide (NMN) Sales in Volume by Country (2016-2026)
8.3.2 Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales by Type (2016-2026)
9.2 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales by Application (2016-2026)
9.3 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Market Size by Region
9.3.1 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America β-Nicotinamide Mononucleotide (NMN) Sales by Type (2016-2026)
10.2 South America β-Nicotinamide Mononucleotide (NMN) Sales by Application (2016-2026)
10.3 South America β-Nicotinamide Mononucleotide (NMN) Market Size by Country
10.3.1 South America β-Nicotinamide Mononucleotide (NMN) Sales in Volume by Country (2016-2026)
10.3.2 South America β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Type (2016-2026)
11.2 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Application (2016-2026)
11.3 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Market Size by Country
11.3.1 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 β-Nicotinamide Mononucleotide (NMN) Typical Distributors
12.3 β-Nicotinamide Mononucleotide (NMN) Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Type, (USD Million), 2021-2026
Table 2. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application, (USD Million), 2021-2026
Table 3. GeneHarbor Basic Information, Manufacturing Base and Competitors
Table 4. GeneHarbor Major Business
Table 5. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 6. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Herbalmax Basic Information, Manufacturing Base and Competitors
Table 8. Herbalmax Major Business
Table 9. Herbalmax β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 10. Herbalmax β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Genex Formulas Basic Information, Manufacturing Base and Competitors
Table 12. Genex Formulas Major Business
Table 13. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 14. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Shinkowa Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 16. Shinkowa Pharmaceutical Major Business
Table 17. Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 18. Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Maac10 Formulas Basic Information, Manufacturing Base and Competitors
Table 20. Maac10 Formulas Major Business
Table 21. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 22. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. EffePharm Basic Information, Manufacturing Base and Competitors
Table 24. EffePharm Major Business
Table 25. EffePharm β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 26. EffePharm β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Bontac Basic Information, Manufacturing Base and Competitors
Table 28. Bontac Major Business
Table 29. Bontac β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 30. Bontac β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. CELFULL Basic Information, Manufacturing Base and Competitors
Table 32. CELFULL Major Business
Table 33. CELFULL β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 34. CELFULL β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Kingdomway Basic Information, Manufacturing Base and Competitors
Table 36. Kingdomway Major Business
Table 37. Kingdomway β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 38. Kingdomway β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global β-Nicotinamide Mononucleotide (NMN) Sales by Manufacturer (2019-2021e) & (Kg)
Table 40. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in β-Nicotinamide Mononucleotide (NMN), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global β-Nicotinamide Mononucleotide (NMN) Production Capacity by Company, (Kg): 2020 VS 2021
Table 43. Head Office and β-Nicotinamide Mononucleotide (NMN) Production Site of Key Manufacturer
Table 44. β-Nicotinamide Mononucleotide (NMN) New Entrant and Capacity Expansion Plans
Table 45. β-Nicotinamide Mononucleotide (NMN) Mergers & Acquisitions in the Past Five Years
Table 46. Global β-Nicotinamide Mononucleotide (NMN) Sales by Region (2016-2021e) & (Kg)
Table 47. Global β-Nicotinamide Mononucleotide (NMN) Sales by Region (2021-2026) & (Kg)
Table 48. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2016-2021e) & (USD Million)
Table 49. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2021-2026) & (USD Million)
Table 50. Global β-Nicotinamide Mononucleotide (NMN) Sales by Type (2016-2021e) & (Kg)
Table 51. Global β-Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026) & (Kg)
Table 52. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Type (2016-2021e) & (USD Million)
Table 53. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Type (2021-2026) & (USD Million)
Table 54. Global β-Nicotinamide Mononucleotide (NMN) Price by Type (2016-2021e) & (US$/Kg)
Table 55. Global β-Nicotinamide Mononucleotide (NMN) Price by Type (2021-2026) & (US$/Kg)
Table 56. Global β-Nicotinamide Mononucleotide (NMN) Sales by Application (2016-2021e) & (Kg)
Table 57. Global β-Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026) & (Kg)
Table 58. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2016-2021e) & (USD Million)
Table 59. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2026) & (USD Million)
Table 60. Global β-Nicotinamide Mononucleotide (NMN) Price by Application (2016-2021e) & (US$/Kg)
Table 61. Global β-Nicotinamide Mononucleotide (NMN) Price by Application (2021-2026) & (US$/Kg)
Table 62. North America β-Nicotinamide Mononucleotide (NMN) Sales by Country (2016-2021e) & (Kg)
Table 63. North America β-Nicotinamide Mononucleotide (NMN) Sales by Country (2021-2026) & (Kg)
Table 64. North America β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2016-2021e) & (USD Million)
Table 65. North America β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2021-2026) & (USD Million)
Table 66. North America β-Nicotinamide Mononucleotide (NMN) Sales by Type (2016-2021e) & (Kg)
Table 67. North America β-Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026) & (Kg)
Table 68. North America β-Nicotinamide Mononucleotide (NMN) Sales by Application (2016-2021e) & (Kg)
Table 69. North America β-Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026) & (Kg)
Table 70. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Country (2016-2021e) & (Kg)
Table 71. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Country (2021-2026) & (Kg)
Table 72. Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2016-2021e) & (USD Million)
Table 73. Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2021-2026) & (USD Million)
Table 74. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Type (2016-2021e) & (Kg)
Table 75. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026) & (Kg)
Table 76. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Application (2016-2021e) & (Kg)
Table 77. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026) & (Kg)
Table 78. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales by Region (2016-2021e) & (Kg)
Table 79. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales by Region (2021-2026) & (Kg)
Table 80. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2016-2021e) & (USD Million)
Table 81. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2021-2026) & (USD Million)
Table 82. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales by Type (2016-2021e) & (Kg)
Table 83. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026) & (Kg)
Table 84. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales by Application (2016-2021e) & (Kg)
Table 85. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026) & (Kg)
Table 86. South America β-Nicotinamide Mononucleotide (NMN) Sales by Country (2016-2021e) & (Kg)
Table 87. South America β-Nicotinamide Mononucleotide (NMN) Sales by Country (2021-2026) & (Kg)
Table 88. South America β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2016-2021e) & (USD Million)
Table 89. South America β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2021-2026) & (USD Million)
Table 90. South America β-Nicotinamide Mononucleotide (NMN) Sales by Type (2016-2021e) & (Kg)
Table 91. South America β-Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026) & (Kg)
Table 92. South America β-Nicotinamide Mononucleotide (NMN) Sales by Application (2016-2021e) & (Kg)
Table 93. South America β-Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026) & (Kg)
Table 94. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Country (2016-2021e) & (Kg)
Table 95. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Country (2021-2026) & (Kg)
Table 96. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2016-2021e) & (USD Million)
Table 97. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2021-2026) & (USD Million)
Table 98. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Type (2016-2021e) & (Kg)
Table 99. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026) & (Kg)
Table 100. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Application (2016-2021e) & (Kg)
Table 101. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026) & (Kg)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. β-Nicotinamide Mononucleotide (NMN) Typical Distributors
Table 105. β-Nicotinamide Mononucleotide (NMN) Typical Customers
List of Figures
Figure 1. β-Nicotinamide Mononucleotide (NMN) Picture
Figure 2. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type in 2020
Figure 3. Above 98%
Figure 4. Below 98%
Figure 5. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application in 2020
Figure 6. Health Care Products
Figure 7. Cosmetics
Figure 8. Others
Figure 9. Global β-Nicotinamide Mononucleotide (NMN) Market Size, (USD Million) & (Kg): 2020 VS 2021 VS 2026
Figure 10. Global β-Nicotinamide Mononucleotide (NMN) Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global β-Nicotinamide Mononucleotide (NMN) Sales (2016-2026) & (Kg)
Figure 12. Global β-Nicotinamide Mononucleotide (NMN) Price by Type (2016-2026) & (US$/Kg)
Figure 13. Global β-Nicotinamide Mononucleotide (NMN) Production Capacity (2016-2026) & (Kg)
Figure 14. Global β-Nicotinamide Mononucleotide (NMN) Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. β-Nicotinamide Mononucleotide (NMN) Market Drivers
Figure 16. β-Nicotinamide Mononucleotide (NMN) Market Restraints
Figure 17. β-Nicotinamide Mononucleotide (NMN) Market Trends
Figure 18. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Manufacturer in 2020
Figure 19. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Manufacturer in 2020
Figure 20. β-Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 β-Nicotinamide Mononucleotide (NMN) Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 β-Nicotinamide Mononucleotide (NMN) Manufacturer (Revenue) Market Share in 2020
Figure 23. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2016-2026)
Figure 24. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2016-2026)
Figure 25. North America β-Nicotinamide Mononucleotide (NMN) Revenue (2016-2026) & (USD Million)
Figure 26. Europe β-Nicotinamide Mononucleotide (NMN) Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Revenue (2016-2026) & (USD Million)
Figure 28. South America β-Nicotinamide Mononucleotide (NMN) Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Revenue (2016-2026) & (USD Million)
Figure 30. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2016-2026)
Figure 31. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2016-2026)
Figure 32. Global β-Nicotinamide Mononucleotide (NMN) Price by Type (2016-2026) & (US$/Kg)
Figure 33. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2016-2026)
Figure 34. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2016-2026)
Figure 35. Global β-Nicotinamide Mononucleotide (NMN) Price by Application (2016-2026) & (US$/Kg)
Figure 36. North America β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2016-2026)
Figure 37. North America β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2016-2026)
Figure 38. North America β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2016-2026)
Figure 39. North America β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2016-2026)
Figure 40. United States β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2016-2026)
Figure 44. Europe β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2016-2026)
Figure 45. Europe β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2016-2026)
Figure 46. Europe β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2016-2026)
Figure 47. Germany β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2016-2026)
Figure 56. China β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2016-2026)
Figure 63. South America β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2016-2026)
Figure 64. South America β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2016-2026)
Figure 65. South America β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2016-2026)
Figure 66. Brazil β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2016-2026)
Figure 72. Turkey β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source

---